These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 29398356)

  • 1. A Subpopulation of Striatal Neurons Mediates Levodopa-Induced Dyskinesia.
    Girasole AE; Lum MY; Nathaniel D; Bair-Marshall CJ; Guenthner CJ; Luo L; Kreitzer AC; Nelson AB
    Neuron; 2018 Feb; 97(4):787-795.e6. PubMed ID: 29398356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Striatal Activity in Parkinsonism and Levodopa-Induced Dyskinesia.
    Ryan MB; Bair-Marshall C; Nelson AB
    Cell Rep; 2018 Jun; 23(12):3438-3446.e5. PubMed ID: 29924988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphological and electrophysiological changes in intratelencephalic-type pyramidal neurons in the motor cortex of a rat model of levodopa-induced dyskinesia.
    Ueno T; Yamada J; Nishijima H; Arai A; Migita K; Baba M; Ueno S; Tomiyama M
    Neurobiol Dis; 2014 Apr; 64():142-9. PubMed ID: 24398173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional regulation of levodopa-induced dyskinesia by a specific neural ensemble in globus pallidus external segment.
    Shen C; Shen B; Liu D; Han L; Zou K; Gan L; Ren J; Wu B; Tang Y; Zhao J; Sun Y; Liu F; Yu W; Yao H; Wu J; Wang J
    Cell Rep Med; 2024 Jun; 5(6):101566. PubMed ID: 38759649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
    Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.
    Sellnow RC; Steece-Collier K; Altwal F; Sandoval IM; Kordower JH; Collier TJ; Sortwell CE; West AR; Manfredsson FP
    J Neurosci; 2020 Apr; 40(18):3675-3691. PubMed ID: 32238479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of glutamic acid decarboxylase (Gad67) in striatal neurons expressing the Drdr1a dopamine receptor prevents L-DOPA-induced dyskinesia in 6-hydroxydopamine-lesioned mice.
    Zhang K; Chammas C; Soghomonian JJ
    Neuroscience; 2015 Sep; 303():586-94. PubMed ID: 26188284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiology of dopamine in normal and denervated striatal neurons.
    Calabresi P; Centonze D; Bernardi G
    Trends Neurosci; 2000 Oct; 23(10 Suppl):S57-63. PubMed ID: 11052221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM; Solís O; Caramés JM; Taravini IR; Solís JM; Murer MG; Moratalla R
    Biol Psychiatry; 2014 May; 75(9):711-22. PubMed ID: 23769604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derangement of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) and extracellular signal-regulated kinase (ERK) dependent striatal plasticity in L-DOPA-induced dyskinesia.
    Cerovic M; Bagetta V; Pendolino V; Ghiglieri V; Fasano S; Morella I; Hardingham N; Heuer A; Papale A; Marchisella F; Giampà C; Calabresi P; Picconi B; Brambilla R
    Biol Psychiatry; 2015 Jan; 77(2):106-15. PubMed ID: 24844602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Axial levodopa-induced dyskinesias and neuronal activity in the dorsal striatum.
    Alberico SL; Kim YC; Lence T; Narayanan NS
    Neuroscience; 2017 Feb; 343():240-249. PubMed ID: 27956068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of striatal Ca
    Caulfield ME; Vander Werp MJ; Stancati JA; Collier TJ; Sortwell CE; Sandoval IM; Manfredsson FP; Steece-Collier K
    Neurobiol Dis; 2023 Jun; 181():106111. PubMed ID: 37001610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal dopaminergic modulation of striato-cortical networks underlies levodopa-induced dyskinesias in humans.
    Herz DM; Haagensen BN; Christensen MS; Madsen KH; Rowe JB; Løkkegaard A; Siebner HR
    Brain; 2015 Jun; 138(Pt 6):1658-66. PubMed ID: 25882651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons.
    Klietz M; Keber U; Carlsson T; Chiu WH; Höglinger GU; Weihe E; Schäfer MK; Depboylu C
    Neuroscience; 2016 Sep; 331():120-33. PubMed ID: 27320210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal tyrosine hydroxylase-positive neurons are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice.
    Keber U; Klietz M; Carlsson T; Oertel WH; Weihe E; Schäfer MK; Höglinger GU; Depboylu C
    Neuroscience; 2015 Jul; 298():302-17. PubMed ID: 25892702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased striatal pre-proenkephalin B expression is associated with dyskinesia in Parkinson's disease.
    Henry B; Duty S; Fox SH; Crossman AR; Brotchie JM
    Exp Neurol; 2003 Oct; 183(2):458-68. PubMed ID: 14552886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats.
    Steece-Collier K; Collier TJ; Lipton JW; Stancati JA; Winn ME; Cole-Strauss A; Sellnow R; Conti MM; Mercado NM; Nillni EA; Sortwell CE; Manfredsson FP; Bishop C
    Exp Neurol; 2020 Aug; 330():113327. PubMed ID: 32387398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of levodopa dose and magnitude of dopamine depletion as risk factors for levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Putterman DB; Munhall AC; Kozell LB; Belknap JK; Johnson SW
    J Pharmacol Exp Ther; 2007 Oct; 323(1):277-84. PubMed ID: 17660384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CK2 Oppositely Modulates l-DOPA-Induced Dyskinesia via Striatal Projection Neurons Expressing D1 or D2 Receptors.
    Cortés M; Malave L; Castello J; Flajolet M; Cenci MA; Friedman E; Rebholz H
    J Neurosci; 2017 Dec; 37(49):11930-11946. PubMed ID: 29097596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment.
    Belujon P; Lodge DJ; Grace AA
    Mov Disord; 2010 Aug; 25(11):1568-76. PubMed ID: 20623773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.